Edition:
United States

Biotechnology & Medical Research

Page 1

Oncolytics Biotech Receives Shareholder Approval To Consolidate Company's Common Shares At Its February 23, 2018 Special Meeting Of Shareholders

Friday, 23 Feb 2018 05:27pm EST

Feb 23 (Reuters) - Oncolytics Biotech Inc ::ONCOLYTICS BIOTECH INC - RECEIVED SHAREHOLDER APPROVAL TO CONSOLIDATE COMPANY'S COMMON SHARES AT ITS FEBRUARY 23, 2018 SPECIAL MEETING OF SHAREHOLDERS.

Tenax Therapeutics Announces Reverse Stock Split

Friday, 23 Feb 2018 08:00am EST

Feb 23 (Reuters) - Tenax Therapeutics Inc ::TENAX THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT.TENAX THERAPEUTICS INC - ‍REVERSE STOCK SPLIT OF ITS SHARES OF COMMON STOCK AT A RATIO OF 1-FOR-20​.

Dova Pharmaceuticals Says Public Offering Of 2.50 Mln Shares Priced At $32 per Share

Thursday, 22 Feb 2018 07:30pm EST

Feb 22 (Reuters) - Dova Pharmaceuticals Inc ::DOVA PHARMACEUTICALS, INC. ANNOUNCES PRICING OF OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 2.50 MILLION COMMON SHARES PRICED AT $32.00 PER SHARE.

Advaxis Prices $20.0 Mln Public Offering Of Common Stock

Thursday, 22 Feb 2018 09:15am EST

Feb 22 (Reuters) - Advaxis Inc ::ADVAXIS PRICES $20.0 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 10.0 MILLION COMMON SHARES PRICED AT $2.00PER SHARE.

Advaxis Announces Proposed Public Offering Of Common Stock

Wednesday, 21 Feb 2018 04:05pm EST

Feb 21 (Reuters) - Advaxis Inc ::ADVAXIS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.

Dova Pharmaceuticals Announces Proposed Offering Of Common Stock

Tuesday, 20 Feb 2018 04:05pm EST

Feb 20 (Reuters) - Dova Pharmaceuticals Inc ::DOVA PHARMACEUTICALS, INC. ANNOUNCES PROPOSED OFFERING OF COMMON STOCK.SAYS OFFERING 2.50 MILLION COMMON SHARES.

Trans Genic says exercise of options

Monday, 19 Feb 2018 04:00am EST

Feb 19 (Reuters) - Trans Genic Inc <2342.T>:Says 419 units of its 5th series options were exercised to 419,000 shares of its common stock, from Feb. 1 to Feb. 19 .

Selvita Sets Final Price Of 2.2 Mln Series H Shares At 61 Zlotys/Shr

Friday, 16 Feb 2018 03:36am EST

Feb 16 (Reuters) - SELVITA SA ::SAID ON THURSDAY THE COMPANY SET FINAL PRICE OF 2.2 MLN SERIES H SHARES AT 61 ZLOTYS PER SHARE.

Patrys ‍Raises $2.4 Mln (Before Costs) Through Rights Issue​

Thursday, 15 Feb 2018 08:43pm EST

Feb 16 (Reuters) - Patrys Ltd ::‍ RAISES $2.4 MILLION (BEFORE COSTS) THROUGH RIGHTS ISSUE​.

MabVax Therapeutics Says Reverse Stock Split Is Scheduled To Be Effective With Opening Of Trading On Feb 16

Thursday, 15 Feb 2018 07:30am EST

Feb 15 (Reuters) - MabVax Therapeutics Holdings Inc ::MABVAX THERAPEUTICS SCHEDULES PREVIOUSLY ANNOUNCED 1-FOR-3 REVERSE STOCK SPLIT TO REGAIN COMPLIANCE WITH NASDAQ'S $1.00 MINIMUM BID PRICE MAINTENANCE REQUIREMENT.MABVAX THERAPEUTICS HOLDINGS INC - REVERSE STOCK SPLIT IS SCHEDULED TO BE EFFECTIVE WITH OPENING OF TRADING ON FEB 16, 2018.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary